The Journal of Urology
Volume 170, Issue 1 , Pages 166-169, July 2003

Clinical, Demographic and Psychosocial Correlates of Complementary and Alternative Medicine Use by Men Diagnosed With Localized Prostate Cancer

From the Division of Population Science, Fox Chase Cancer Center, Cheltenham, Pennsylvania

Accepted 3 January 2003.

ABSTRACT 

Purpose

We examined complementary and alternative medicine (CAM) use among men who received standard therapy for localized prostate cancer.

Materials and Methods

A total of 417 men completed a questionnaire 6 months after their treatment decision assessing clinical and psychosocial variables and use of 41 available CAM therapies grouped into the 2 general categories of herbal/dietary and nonherbal (ie mind-body, bioelectromagnetic, traditional/folk medicine, pharmacological/biological).

Results

The prostate cancer diagnosis prompted 19% of our sample to start using some form of CAM for prostate health, and 67% of men reported having used some form of CAM for prostate health before being diagnosed. Initiation of CAM was associated with being a member of an ethnic minority group and a higher level of education. Initiation of nonherbal CAM was associated with being married, while use of herbal CAM therapies was significantly associated with choosing observation. Herbal use before diagnosis was associated with being white, higher level of education and being single. Prostate specific antigen at diagnosis, Gleason score, quality of life, participant perceptions of seriousness of prostate cancer or self-reported worry about prostate cancer were not related to initiation or prior use. Of those men reporting current use almost 50% did not inform their treating physician of using CAM therapies.

Conclusions

Initiation of CAM therapies as a result of a prostate cancer diagnosis was fairly low, although two-thirds of men had used it before diagnosis. Half of the patients did not inform their physicians about such use and physicians should continue to probe patients about CAM use.

Key Words:  prostatic neoplasms, complementary therapies, surgery , radiotherapy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by Grants CA6136-04 (for manuscript preparation) and CA06927 for the Behavioral Core Research Facility at Fox Chase Cancer Center from the National Cancer Institute, Grant PADOH ME-98155 from the Commonwealth of Pennsylvania and Grant DAMD 17-01-1-0006 from the Department of Defense.

PII: S0022-5347(05)63460-X

doi:10.1097/01.ju.0000070963.12496.cc

The Journal of Urology
Volume 170, Issue 1 , Pages 166-169, July 2003